Last Updated: 08/11/2024
Support for Tafenoquine Phase III Trial in India
Objectives
To support a Phase 3 trial of tafenoquine for the radical cure of P. vivax malaria to enable licensure in India.
Principal Institution
Principal Investigators / Focal Persons
External reference
Thematic Categories
Date
Nov 2023 — Nov 2026
Total Project Funding
$2.97M
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-061727
Project Site
Related Resources
